新型冠状病毒肺炎对心血管系统疾病的影响

胡 春霞¹, 贺 利平²
1、内蒙古医科大学
2、内蒙古自治区人民医院心血管内科

摘要

2019年冠状病毒病（COVID-19）大流行由新型冠状病毒家族成员严重急性呼吸综合征冠状病毒2（SARS-CoV-2）
引起，除肺部表现外，还与多器官系统的许多疾病表现相关。COVID-19还伴有几种心血管病变，包括心肌炎、急性心肌梗
死、应激性心肌病、动脉和静脉血栓栓塞、心包炎和心律失常。这些临床症状的病理生理学机制是多因素的，包括全身性炎
症（细胞因子风暴）、凝血病、通过血管紧张素转换酶2的直接病毒入侵、低氧血症、电解质失衡和发热。本文旨在根据最
新证据，从临床特征、发病机制等方面综述COVID-19大流行中的心血管疾病。

关键词

新型冠状病毒；新型冠状病毒肺炎；心血管疾病

参考

[1]DROSTEN C, GüNTHER S, PREISER W, et al. Identification of a novel coronavirus in patients with severe

acute respiratory syndrome [J]. The New England journal of medicine, 2003, 348(20): 1967-76. [2]ZAKI A M, VAN BOHEEMEN S, BESTEBROER T M, et al. Isolation of a novel coronavirus from a man with

pneumonia in Saudi Arabia [J]. The New England journal of medicine, 2012, 367(19): 1814-20. [3]ZHOU P, YANG X L, WANG X G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin [J]. Nature, 2020, 579(7798): 270-3. [4]LU R, ZHAO X, LI J, et al. Genomic characterisation

and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding [J]. Lancet (London, England), 2020, 395(10224): 565-74. [5]HUANG C, WANG Y, LI X, et al. Clinical features of

patients infected with 2019 novel coronavirus in Wuhan, China

[J]. Lancet (London, England), 2020, 395(10223): 497-506. [6]XIONG T Y, REDWOOD S, PRENDERGAST B, et al. Coronaviruses and the cardiovascular system: acute and long_xfffe_term implications [J]. European heart journal, 2020, 41(19): 1798-800. [7]HE L, DING Y, ZHANG Q, et al. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV_xfffe_infected ACE2+ cells in SARS patients: relation to the acute

lung injury and pathogenesis of SARS [J]. The Journal of

pathology, 2006, 210(3): 288-97. [8]REGLA-NAVA J A, JIMENEZ-GUARDEñO J M, NIETO-TORRES J L, et al. The replication of a mouse adapted

SARS-CoV in a mouse cell line stably expressing the murine SARS-CoV receptor mACE2 efficiently induces the expression

of proinflammatory cytokines [J]. Journal of virological methods, 2013, 193(2): 639-46. [9]ZHANG J J, DONG X, CAO Y Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China [J]. Allergy, 2020, 75(7): 1730-41. [10]WEI Z Y, QIAN H Y. [Myocardial injury in patients with COVID-19 pneumonia] [J]. Zhonghua xin xue guan bing

za zhi, 2020, 48(0): E006. [11]PARK J, KWOCK C K, YANG Y J. The Effect of the Sodium to Potassium Ratio on Hypertension Prevalence: A

Propensity Score Matching Approach [J]. Nutrients, 2016, 8(8): [12]CROP M J, HOORN E J, LINDEMANS J, et al. Hypokalaemia and subsequent hyperkalaemia in hospitalized

patients [J]. Nephrology, dialysis, transplantation : official

publication of the European Dialysis and Transplant Association

- European Renal Association, 2007, 22(12): 3471-7. [13]SHI S, QIN M, CAI Y, et al. Characteristics and

clinical significance of myocardial injury in patients with severe

coronavirus disease 2019 [J]. European heart journal, 2020, 41(22): 2070-9. [14]GUO T, FAN Y, CHEN M, et al. Cardiovascular

Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) [J]. JAMA cardiology, 2020, 5(7): 811-8.[15]PRASITLUMKUM N, CHOKESUWATTANASKUL

R, THONGPRAYOON C, et al. Incidence of Myocardial Injury

in COVID-19-Infected Patients: A Systematic Review and

Meta-Analysis [J]. Diseases (Basel, Switzerland), 2020, 8(4): [16]PENG Y D, MENG K, GUAN H Q, et al. [Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV] [J]. Zhonghua xin xue guan

bing za zhi, 2020, 48(6): 450-5. [17]TAN W, ABOULHOSN J. The cardiovascular burden

of coronavirus disease 2019 (COVID-19) with a focus on

congenital heart disease [J]. International journal of cardiology, 2020, 309(70-7. [18]KOCHI A N, TAGLIARI A P, FORLEO G B, et al. Cardiac and arrhythmic complications in patients with COVID- 19 [J]. Journal of cardiovascular electrophysiology, 2020, 31(5): 1003-8. [19]DENG Y, LIU W, LIU K, et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study [J]. Chinese medical

journal, 2020, 133(11): 1261-7. [20]WANG D, HU B, HU C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel CoronavirusInfected Pneumonia in Wuhan, China [J]. Jama, 2020, 323(11): 1061-9. [21]ZHOU F, YU T, DU R, et al. Clinical course and risk

factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [J]. Lancet (London, England), 2020, 395(10229): 1054-62. [22]CHEN T, WU D, CHEN H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study [J]. BMJ (Clinical research ed), 2020, 368(m1091.